Murat İnanç
Impact in
- Rheumatology top 0.5%
- Systemic Lupus Erythematosus Research
- Ophthalmology top 1%
- Ocular Diseases and Behçet’s Syndrome
- Retinal and Optic Conditions
Papers in
- Rheumatology 72
- Systemic Lupus Erythematosus Research 52
- Hematology 20
- Platelet Disorders and Treatments 10
- Autoimmune and Inflammatory Disorders Research 9
- Co-authors
- Ahmet GülSevil KamalıOrhan AralMeral KoniçeLale ÖçalBahar Artım-EsenEsen Kasapoğlu GünalReyhan Diz Küçükkaya
- Journals
- Lupus (15 papers)Annals of the Rheumatic Diseases (12 papers)Clinical Rheumatology (9 papers)Lara D. Veeken (7 papers)Modern Rheumatology (4 papers)
- Partner nations
- TürkiyeUnited StatesUnited Kingdom
In The Last Decade
Murat İnanç
116 papers receiving 2.8k citations
Peers
Comparison fields: 5 of 82
- Rheumatology 1.6k
- Ophthalmology 639
- Hematology 463
- Immunology 746
- Nephrology 219
Countries citing papers authored by Murat İnanç
This map shows the geographic impact of Murat İnanç's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat İnanç with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat İnanç more than expected).
Fields of papers citing papers by Murat İnanç
This network shows the impact of papers produced by Murat İnanç. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat İnanç. The network helps show where Murat İnanç may publish in the future.
Co-authors
The 25 scholars most cited alongside Murat İnanç, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2022 | 9 | |
| 4 | 2022 | 3 | |
| 5 | 2022 | 2 | |
| 6 | 2021 | 0 | |
| 7 | 2021 | 4 | |
| 8 | 2020 | 6 | |
| 9 | Remarkable damage along with poor quality of life in Takayasu arteritis: cross-sectional results of a long-term followed-up multicentre cohort. | 2017 | 14 |
| 10 | Direct and indirect healthcare costs of rheumatoid arthritis patients in Turkey. | 2017 | 9 |
| 11 | 2016 | 8 | |
| 12 | SİSTEMİK LUPUS ERİTEMATOZUS ETYOPATOGENEZİNDE VİRÜSLERİN ROLÜ | 2011 | 0 |
| 13 | 2010 | 90 | |
| 14 | 2009 | 47 | |
| 15 | 2008 | 3 | |
| 16 | 2006 | 69 | |
| 17 | 2005 | 222 | |
| 18 | Efficacy of Infliximab in the Treatment of Uveitis Resistant to the Combination of Azathioprine and Cyclosporin in Behçet's Disease: Preliminary Report of an Open Trial | 2004 | 1 |
| 19 | 2004 | 6 | |
| 20 | Transforming growth factor-12 polymorphism and systemic lupus erythematosus. | 2002 | 3 |
About Murat İnanç
Murat İnanç is a scholar working on Rheumatology, Hematology, Immunology, Ophthalmology and Nephrology, having authored 134 papers that have together received 2.9k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (52 papers), Vasculitis and related conditions (28 papers), Systemic Sclerosis and Related Diseases (19 papers), Ocular Diseases and Behçet’s Syndrome (12 papers), Atherosclerosis and Cardiovascular Diseases (12 papers), Platelet Disorders and Treatments (10 papers), Autoimmune and Inflammatory Disorders Research (9 papers) and Sarcoidosis and Beryllium Toxicity Research (9 papers). The work is most often cited by research in Rheumatology (1.6k citations), Ophthalmology (639 citations), Hematology (463 citations), Immunology (746 citations) and Nephrology (219 citations). Murat İnanç has collaborated with scholars based in Türkiye, United States and United Kingdom. Frequent co-authors include Ahmet Gül, Sevil Kamalı, Orhan Aral, Meral Koniçe, Lale Öçal, Bahar Artım-Esen, Esen Kasapoğlu Günal, Reyhan Diz Küçükkaya, N Dilşen and Ayşe Çefle. Their work appears in journals such as Lupus, Annals of the Rheumatic Diseases, Clinical Rheumatology, Lara D. Veeken and Modern Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.